SOMMERVOLL, Frigg Å. et al. How does pulmonary function impact QoL in patients with locally advanced NSCLC treated with chemoradiotherapy and durvalumab?. Acta Oncologica, [S. l.], v. 65, p. 232–240, 2026. DOI: 10.2340/1651-226X.2026.45040. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/45040. Acesso em: 12 may. 2026.